Glucocorticoid receptor (NR3C1) genetic polymorphisms and the outcomes of sudden sensorineural hearing loss
Abstract Background The glucocorticoid receptor gene (NR3C1) encodes the receptor to which cortisol and other glucocorticoids bind. Steroids in either oral, intratympanic, or intravascular forms are the treatment of choice for sudden sensorineural hearing loss (SSNHL), but the outcome varies. The ou...
Saved in:
Main Authors: | Chen-Yu Chien, Shu-Yu Tai, Kuan-Hui Li, Hua-Ling Yang, Ling-Feng Wang, Kuen-Yao Ho, Ning-Chia Chang |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-02-01
|
Series: | Journal of Otolaryngology - Head and Neck Surgery |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40463-022-00601-w |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hyperbaric oxygen therapy improves the effects of systemic steroid therapy for sudden sensorineural hearing loss
by: Yu-Ching Chen, et al.
Published: (2025-01-01) -
Diagnostic and predictive values of serum metabolic profiles in sudden sensorineural hearing loss patients
by: Xiangsheng Wang, et al.
Published: (2022-09-01) -
Effect of intratympanic steroid therapy in sudden sensorineural hearing loss: Our clinical experience
by: Ahmet Hamdi̇ Kepekci
Published: (2024-04-01) -
Management of sudden sensorineural hearing loss among primary care physicians in Canada: a survey study
by: Benjamin Ng, et al.
Published: (2021-04-01) -
Efficacy and fibrinogen correlations of defibrinogen therapy in idiopathic sudden sensorineural hearing loss
by: Bing Wang, et al.
Published: (2025-02-01)